South China Vaccine Corporation Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 36

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $7.87M

  • Investors
  • 2

South China Vaccine Corporation General Information

Description

Developer of technologies of genetic engineering vaccine. The company engages in technologies of genetically engineered vaccines and established a genetically engineered vaccine research and development and industrialization platform, enabling clients to have high-quality vaccines.

Contact Information

Website
www.gdscvc.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2nd Floor, Building C6, Science and Technology Enterprise Accelerator
  • Guangzhou Development Zone, No. 11, Kaiyuan Avenue
  • Guangzhou, Guangdong 510663
  • China
+86 020
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 2nd Floor, Building C6, Science and Technology Enterprise Accelerator
  • Guangzhou Development Zone, No. 11, Kaiyuan Avenue
  • Guangzhou, Guangdong 510663
  • China
+86 020

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

South China Vaccine Corporation Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 17-Mar-2022 $7.87M Completed Generating Revenue
6. Merger/Acquisition 01-Jul-2021 Completed Generating Revenue
5. Secondary Transaction - Private 01-Jul-2021 Completed Generating Revenue
4. IPO 23-Feb-2018 Completed Generating Revenue
3. Early Stage VC 19-Jun-2015 Completed Generating Revenue
2. Merger/Acquisition 10-Dec-2013 Completed Generating Revenue
1. Secondary Transaction - Private 03-Jun-2013 Completed Generating Revenue
To view South China Vaccine Corporation’s complete valuation and funding history, request access »

South China Vaccine Corporation Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
To view South China Vaccine Corporation’s complete cap table history, request access »

South China Vaccine Corporation Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

South China Vaccine Corporation FAQs

  • When was South China Vaccine Corporation founded?

    South China Vaccine Corporation was founded in 2011.

  • Where is South China Vaccine Corporation headquartered?

    South China Vaccine Corporation is headquartered in Guangzhou, China.

  • What is the size of South China Vaccine Corporation?

    South China Vaccine Corporation has 36 total employees.

  • What industry is South China Vaccine Corporation in?

    South China Vaccine Corporation’s primary industry is Biotechnology.

  • Is South China Vaccine Corporation a private or public company?

    South China Vaccine Corporation is a Private company.

  • What is South China Vaccine Corporation’s current revenue?

    The current revenue for South China Vaccine Corporation is .

  • How much funding has South China Vaccine Corporation raised over time?

    South China Vaccine Corporation has raised $7.87M.

  • When was South China Vaccine Corporation acquired?

    South China Vaccine Corporation was acquired on 17-Mar-2022.

  • Who acquired South China Vaccine Corporation?

    South China Vaccine Corporation was acquired by ApicHope Pharmaceutical Group.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process